Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,911 | 501 | 80.5% |
| Travel and Lodging | $2,683 | 13 | 18.1% |
| Grant | $125.00 | 1 | 0.8% |
| Education | $75.95 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,795 | 58 | $0 (2024) |
| Medtronic, Inc. | $1,613 | 24 | $0 (2024) |
| Boston Scientific Corporation | $1,481 | 24 | $0 (2024) |
| ABIOMED | $1,160 | 9 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $933.60 | 65 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $744.53 | 57 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $715.29 | 41 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $639.44 | 19 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $636.50 | 38 | $0 (2024) |
| Amgen Inc. | $470.76 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $829.38 | 24 | ABIOMED ($308.54) |
| 2023 | $767.23 | 35 | Abbott Laboratories ($153.74) |
| 2022 | $1,583 | 47 | Philips Electronics North America Corporation ($278.54) |
| 2021 | $2,706 | 64 | Medtronic, Inc. ($1,371) |
| 2020 | $285.25 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($82.83) |
| 2019 | $1,380 | 74 | Medtronic Vascular, Inc. ($253.31) |
| 2018 | $3,487 | 123 | Boston Scientific Corporation ($1,067) |
| 2017 | $3,758 | 135 | Abbott Laboratories ($1,716) |
All Payment Transactions
520 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Vascular | ||||||
| 10/24/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Structural Heart | ||||||
| 10/02/2024 | Boston Scientific Corporation | Emerge Push (Device) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Emerge_IC | ||||||
| 09/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/03/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Pacemakers | ||||||
| 08/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $30.39 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $135.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Pacemakers | ||||||
| 06/21/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Structural Heart | ||||||
| 05/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $150.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $31.14 | General |
| Category: Medical Device | ||||||
| 04/15/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $31.14 | General |
| Category: Medical Device | ||||||
| 04/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Cardiovascular | ||||||
| 04/08/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Stents | ||||||
| 04/03/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $136.42 | General |
| Category: Stents | ||||||
| 03/13/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Stents | ||||||
| 02/02/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Stents | ||||||
| 01/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: Cardiovascular | ||||||
| 01/30/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Stents | ||||||
| 01/23/2024 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: PAD | ||||||
| 01/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,790 | 3,580 | $485,845 | $139,420 |
| 2022 | 26 | 2,728 | 3,591 | $488,602 | $145,560 |
| 2021 | 29 | 2,740 | 3,701 | $537,157 | $162,558 |
| 2020 | 32 | 2,979 | 4,151 | $583,463 | $172,605 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 393 | 615 | $139,605 | $49,028 | 35.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 274 | $45,484 | $17,155 | 37.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 333 | 337 | $66,052 | $17,130 | 25.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 103 | 110 | $33,660 | $11,365 | 33.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 109 | 112 | $29,904 | $6,503 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $17,101 | $5,884 | 34.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $13,470 | $4,132 | 30.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 514 | 621 | $16,175 | $3,685 | 22.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $15,876 | $3,320 | 20.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 33 | $7,854 | $3,118 | 39.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 68 | 195 | $15,405 | $2,927 | 19.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 246 | 259 | $19,425 | $2,864 | 14.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 50 | 142 | $13,632 | $2,840 | 20.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 113 | 116 | $8,120 | $1,862 | 22.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 18 | 53 | $8,745 | $1,305 | 14.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 113 | 116 | $8,004 | $1,232 | 15.4% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 23 | 29 | $3,770 | $1,034 | 27.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 121 | 122 | $3,172 | $666.09 | 21.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 44 | 45 | $5,265 | $439.95 | 8.4% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 16 | 16 | $1,376 | $374.41 | 27.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 80 | 80 | $2,080 | $367.24 | 17.7% |
| 93923 | Complete ultrasound study of arm and leg arteries | Facility | 2023 | 26 | 26 | $1,664 | $343.60 | 20.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $2,186 | $333.88 | 15.3% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 21 | 21 | $2,100 | $333.20 | 15.9% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 41 | 41 | $1,558 | $312.62 | 20.1% |
About Dr. Souheil Khoukaz, MD
Dr. Souheil Khoukaz, MD is a Interventional Cardiology healthcare provider based in Festus, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386636868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Souheil Khoukaz, MD has received a total of $14,795 in payments from pharmaceutical and medical device companies, with $829.38 received in 2024. These payments were reported across 520 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($11,911).
As a Medicare-enrolled provider, Khoukaz has provided services to 11,237 Medicare beneficiaries, totaling 15,023 services with total Medicare billing of $620,143. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Festus, MO
- Active Since 08/19/2005
- Last Updated 10/26/2017
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1386636868
Products in Payments
- CardioMEMS HF System (Device) $1,851
- Micra (Device) $1,347
- Impella (Device) $1,160
- LifeVest (Device) $933.60
- XARELTO (Drug) $744.53
- JETSTREAM (Device) $698.70
- ELIQUIS (Drug) $626.33
- ENTRESTO (Drug) $552.87
- Supera peripheral stent system (Device) $439.97
- FARXIGA (Drug) $379.17
- Corlanor (Drug) $356.14
- (5044) MCOT (Device) $315.82
- Resolute (Device) $249.76
- Indigo System (Device) $237.38
- BRILINTA (Drug) $218.65
- WATCHMAN (Device) $218.14
- ONYX FRONTIER (Device) $200.51
- LEQVIO (Drug) $162.42
- PRALUENT (Drug) $148.57
- MULTAQ (Drug) $147.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.